Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Meridian Bioscience, Inc. VIVO | The Vanguard Group | 4,970,105 11.340% | 93,163 (+1.91%) | Filing History |
| 2023-02-03 2:06 pm Sale | 2023-01-31 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 0 0.000% | -2,204,418 (Position Closed) | Filing History |
| 2023-01-31 11:06 am Sale | 2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO | ROYCE & ASSOCIATES LP | 169,512 0.390% | -2,026,122 (-92.28%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,557,772 17.200% | 0 (Unchanged) | Filing History |
| 2023-01-20 5:17 pm Purchase | 2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,557,772 17.200% | 151,847 (+2.05%) | Filing History |
| 2023-01-10 5:22 pm Purchase | 2023-01-06 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,204,418 5.020% | 2,204,418 (New Position) | Filing History |
| 2022-12-02 2:16 pm Sale | 2022-11-30 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,173,294 4.960% | -87,394 (-3.87%) | Filing History |
| 2022-11-02 7:48 pm Purchase | 2022-10-24 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,260,688 5.170% | 12,363 (+0.55%) | Filing History |
| 2022-10-28 4:30 pm Sale | 2022-10-27 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 1,910,919 4.400% | -495,639 (-20.60%) | Filing History |
| 2022-10-18 4:45 pm Sale | 2022-10-14 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 2,406,558 5.500% | -494,628 (-17.05%) | Filing History |
| 2022-09-19 4:51 pm Sale | 2022-09-15 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 2,901,186 6.600% | -639,355 (-18.06%) | Filing History |
| 2022-09-19 12:23 pm Purchase | 2022-09-07 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,248,325 5.140% | 2,248,325 (New Position) | Filing History |
| 2022-09-07 4:36 pm Sale | 2022-09-02 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 3,540,541 8.100% | -781,428 (-18.08%) | Filing History |
| 2022-08-10 10:22 am Sale | 2022-07-31 | 13G | Meridian Bioscience, Inc. VIVO | EARNEST PARTNERS LLC | 138,110 0.300% | -3,586,200 (-96.29%) | Filing History |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | James E. Flynn | 1,125,083 2.590% | -1,035,917 (-47.94%) | Filing History |
| 2022-02-10 6:20 pm Sale | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | Renaissance Technologies LLC | 1,913,304 4.400% | -400,560 (-17.31%) | Filing History |
| 2022-02-10 08:53 am Sale | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | EARNEST PARTNERS LLC | 3,724,310 8.600% | -617,524 (-14.22%) | Filing History |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | The Vanguard Group | 4,876,942 11.210% | 119,227 (+2.51%) | Filing History |
| 2022-02-04 5:09 pm Purchase | 2022-01-25 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 4,321,969 9.900% | 4,321,969 (New Position) | Filing History |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,405,925 17.000% | 0 (Unchanged) | Filing History |